Seven Mile Advisory’s Pfizer PFE Stock Holding History

Seven Mile Advisory’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$254K	Sell	9,039 -3,380	-27%	-$90K	0.18%	128
2025 Q4	$309K	Sell	12,419 -195	-2%	-$4.92K	0.05%	167
2025 Q3	$321K	Buy	12,614 +3,200	+34%	+$79K	0.05%	193
2025 Q2	$228K	Buy	+9,414	New	+$220K	0.14%	152
2024 Q4	–	Sell	-6,938	Closed	-$201K	–	179
2024 Q3	$201K	Buy	+6,938	New	+$202K	0.13%	162
2024 Q2	–	Sell	-8,096	Closed	-$225K	–	167
2024 Q1	$225K	Sell	8,096 -2,359	-23%	-$65.5K	0.17%	132
2023 Q4	$301K	Buy	10,455 +536	+5%	+$16.2K	0.26%	88
2023 Q3	$329K	Buy	9,919 +902	+10%	+$31.9K	0.35%	69
2023 Q2	$331K	Buy	+9,017	New	+$351K	0.39%	66

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Seven Mile Advisory's PFE Position: Q1 2026 in Review

Seven Mile Advisory reduced its Pfizer (PFE) stake by 27% in Q1 2026, selling an estimated $90K and leaving 9,039 shares worth $254K. The position accounts for 0.18% of the portfolio, ranked #128.

Seven Mile Advisory first reported a position in PFE in Q2 2023 and has held it in 9 quarters since. The position peaked at $331K in Q2 2023. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Seven Mile Advisory held 9,039 shares of Pfizer worth $254K as of Q1 2026.
Seven Mile Advisory sold 3,380 Pfizer shares in Q1 2026, an estimated $90K.
Pfizer made up 0.18% of Seven Mile Advisory's portfolio in Q1 2026, its #128 holding.
Seven Mile Advisory first reported a position in Pfizer in Q2 2023 and has held it in 9 quarters since.
Seven Mile Advisory's Pfizer position peaked at $331K in Q2 2023.
2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Seven Mile Advisory's 13F filing for Q1 2026, filed 14 Apr 2026.